Ribeiro Suzana Meira, Cardoso Marlon Henrique, Cândido Elizabete de Souza, Franco Octávio Luiz
Centro de Análises Proteômicas e Bioquímicas, Programa de Pós-Graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília-DF, Brazil.
S-Inova, Pós-Graduação em Biotecnologia, Universidade Católica Dom Bosco, Campo Grande- MS, Brazil.
Future Microbiol. 2016;11(4):527-38. doi: 10.2217/fmb.16.7. Epub 2016 Apr 11.
The ability of pathogenic bacteria to aggregate and form biofilm represents a great problem for public health, since they present extracellular components that encase these micro-organisms, making them more resistant to antibiotics and host immune attack. This may become worse when antibiotic-resistant bacterial strains form biofilms. However, antibiofilm screens with different compounds may reveal potential therapies to prevent/treat biofilm infections. Here, we focused on Klebsiella pneumoniae, an opportunistic bacterium that causes different types of infections, including in the bloodstream, meninges, lungs, urinary system and at surgical sites. We also highlight aspects involved in the formation and maintenance of K. pneumoniae biofilms, as well as resistance and the emergence of new trends to combat this health challenge.
致病细菌聚集并形成生物膜的能力对公共卫生构成了重大问题,因为它们呈现出包裹这些微生物的细胞外成分,使其对抗生素和宿主免疫攻击更具抗性。当抗生素耐药菌株形成生物膜时,情况可能会变得更糟。然而,用不同化合物进行的抗生物膜筛选可能会揭示预防/治疗生物膜感染的潜在疗法。在这里,我们重点研究了肺炎克雷伯菌,这是一种机会致病菌,可引起不同类型的感染,包括血液、脑膜、肺部、泌尿系统和手术部位的感染。我们还强调了肺炎克雷伯菌生物膜形成和维持所涉及的方面,以及对抗这一健康挑战的耐药性和新趋势的出现。